Methylation patterns in marginal zone lymphoma

被引:6
|
作者
Arribas, Alberto J. [1 ]
Bertoni, Francesco [1 ,2 ]
机构
[1] Oncol Res Inst, Lymphoma & Genom Res Program, Bellinzona, Switzerland
[2] Oncol Inst Southern Switzerland IOSI, Bellinzona, Switzerland
关键词
Lymphoma; Methylation; Decitabine; Marginal zone; MALT; CIMP; B-CELL LYMPHOMA; CHLAMYDOPHILA-PSITTACI INFECTION; DNA METHYLATION; HELICOBACTER-PYLORI; PROMOTER METHYLATION; SOMATIC MUTATIONS; GENE-EXPRESSION; MALT LYMPHOMAS; MULTIPLE GENES; CPG ISLAND;
D O I
10.1016/j.beha.2016.09.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Promoter DNA methylation is a major regulator of gene expression and transcription. The identification of methylation changes is important for understanding disease pathogenesis, for identifying prognostic markers and can drive novel therapeutic approaches. In this review we summarize the current knowledge regarding DNA methylation in MALT lymphoma, splenic marginal zone lymphoma, nodal marginal zone lymphoma. Despite important differences in the study design for different publications and the existence of a sole large and genome-wide methylation study for splenic marginal zone lymphoma, it is clear that DNA methylation plays an important role in marginal zone lymphomas, in which it contributes to the inactivation of tumor suppressors but also to the expression of genes sustaining tumor cell survival and proliferation. Existing preclinical data provide the rationale to target the methylation machinery in these disorders. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:24 / 31
页数:8
相关论文
共 50 条
  • [31] New Agents in Marginal Zone Lymphoma
    Lossos, Izidore S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S9 - S10
  • [32] TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA
    Julhakyan, H.
    Grjimolovskiy, A.
    Karagulyan, S.
    Magomedova, A.
    Kremenetskaya, A.
    Kravchenko, S.
    Obukhova, T.
    Kaplanskaya, I.
    Samoylova, R.
    Vorobjev, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 622 - 622
  • [33] Primary Cutaneous Marginal Zone Lymphoma
    Ulas, T.
    Tazegul, G.
    Erdem, R.
    Iltar, U.
    Yucel, O. K.
    Salim, O.
    Akkaya, B.
    Undar, L.
    WEST INDIAN MEDICAL JOURNAL, 2024, 71 (01): : 112 - 113
  • [34] Cutaneous involvement with marginal zone lymphoma
    Gerami, Pedram
    Wickless, Scott C.
    Querfeld, Christiane
    Rosen, Steven T.
    Kuzel, Timothy M.
    Guitart, Joan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (01) : 142 - 145
  • [35] Current Treatments in Marginal Zone Lymphoma
    Alderuccio, Juan Pablo
    Kahl, Brad S.
    ONCOLOGY-NEW YORK, 2022, 36 (04): : 206 - 215
  • [36] Primary cutaneous marginal zone lymphoma
    Dalle, Stephane
    Thomas, Luc
    Balme, Brigitte
    Dumontet, Charles
    Thieblemont, Catherine
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 74 (03) : 156 - 162
  • [37] Recent developments in marginal zone lymphoma
    Raderer, Markus
    Kiesewetter, Barbara
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (04) : 247 - 250
  • [38] Treatment of splenic marginal zone lymphoma
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Angelopoulou, Maria K.
    Vassilakopoulos, Theodoros P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (1-2) : 139 - 148
  • [39] SPLENIC MARGINAL ZONE CELL LYMPHOMA
    SCHMID, C
    KIRKHAM, N
    DISS, T
    ISAACSON, PG
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (05) : 455 - 466
  • [40] A CASE WITH SPLENIC MARGINAL ZONE LYMPHOMA
    Cagliyan, G. Akgun
    LEUKEMIA RESEARCH, 2016, 49 : S34 - S34